e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Innovative treatments in sleep disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of bi-level therapy in obstructive sleep apnoea
T. Gentina, F. Fortin, B. Douay, J. M. Dernis, F. Herengt, J. C. Bout, C. Lamblin (Lille, France)
Source:
Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Session:
Innovative treatments in sleep disordered breathing
Session type:
Oral Presentation
Number:
381
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Gentina, F. Fortin, B. Douay, J. M. Dernis, F. Herengt, J. C. Bout, C. Lamblin (Lille, France). The role of bi-level therapy in obstructive sleep apnoea. Eur Respir J 2008; 32: Suppl. 52, 381
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Related content which might interest you:
Non-CPAP therapies in obstructive sleep apnoea
Source: Guideline 2011
Year: 2011
Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 103s
Year: 2002
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
The velumount device for obstructive sleep apnoea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002
Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018
CPAP therapy in idiopathic pulmonary fibrosis patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010
Auto-titrating CPAP for treating obstructive sleep apnoea, a bimodal response in males?
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006
Prevalence of complex sleep apnea (CompSAS) during manual CPAP titration for obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Evaluation of a new automatic CPAP algorithm in the treatment of the obstructive sleep apnea syndrome
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate?
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005
Efficacy of an automatic positive airway pressure system for treatment of obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 9s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept